William Kaelin, MD: Targeting Cancer's Weakness | Dana-Farber Cancer Institute

William G. Kaelin Jr., MD, Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, explains how genetic anomalies lead to cancer and how Dana-Farber’s scientists are uniquely positioned to develop novel agents to target these mutations.